Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Main Index

View All
T-cell immunoglobulin and mucin domain-containing molecule-3 (TIM-3)
TCHP
TDM1
ten-eleven translocation (TET)
TET
tetrahydrofolate (THF)
therapeutic drug monitoring (TDM)
THF
thiotepa (TT)
thrombotic thrombocytopenic purpura (TTP)
thymidylate synthase (TS) Antimetabolites: Hydroxyurea, Pyrimidine and Purine Analogs, and L-Asparaginase Antimetabolites: Antifolates
TIM-3
TKI
TMB
t-MN
TNFα
topoisomerase I (TOP1)
topoisomerase II (TOP2) DNA Repair, Apoptotic Pathways, CDK Inhibitors Answer 6.1
Topoisomerases endogenous enzymes, DNA damage inhibitors\|clinical considerations function and therapeutic targeting of DNA topoisomerase I and II inhibitors\|pharmacologic considerations
toxic epidermal necrolysis (TEN)
TRAIL
transcription factors (TF)
Transplant-relayed agents
transurethral resection of bladder tumor (TURBT) Question 6.4 Answer 6.4
Tregs
TSC
TT
TTP
tumor lysis syndrome (TLS)
tumor microenvironment (TME) overview pharmacokinetics differentiation syndrome pharmacodynamics stem cells